-
Published21/03/2024
-
Deadline08/04/2024
-
Opening of tenders09/04/2024
-
Today19/09/2026
Utilities
- indicates text translated automatically in your browsing language
Completion of a non-exclusive. Discount contract pursuant to Section 130a(8) or 130c(1) SGB V for the period from 1.5.2024 to 30.4.2026
The purpose of this publication is to conclude rebate agreements pursuant to Sections 130a(8) or 130c(1) of the SGB. It is not the award of public contracts within the meaning of Directive 2014/24/EU or Sections 97 et seq. of the GWB. Any pharmaceutical entrepreneur can become a contractual partner in accordance with § 4 para. 18 AMG. According to the case-law of the CJEU, such admission procedures are not necessarily subject to public procurement law, as there is no competition due to the lack of a selection decision. The notice serves as an invitation to conclude rebate agreements with conditions that apply equally to all contracting parties and non-dispositive conditions, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.